1. Home
  2. NNY vs CGTX Comparison

NNY vs CGTX Comparison

Compare NNY & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Municipal Value Fund

NNY

Nuveen New York Municipal Value Fund

HOLD

Current Price

$8.66

Market Cap

164.1M

Sector

Finance

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.37

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNY
CGTX
Founded
1987
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.1M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NNY
CGTX
Price
$8.66
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
50.9K
953.6K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
4.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.58
$0.22
52 Week High
$8.87
$3.83

Technical Indicators

Market Signals
Indicator
NNY
CGTX
Relative Strength Index (RSI) 62.53 40.42
Support Level $8.53 $1.37
Resistance Level $8.74 $1.62
Average True Range (ATR) 0.18 0.12
MACD 0.02 -0.02
Stochastic Oscillator 53.13 0.00

Price Performance

Historical Comparison
NNY
CGTX

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: